Page last updated: 2024-10-24

buspirone and Amphetamine-Related Disorders

buspirone has been researched along with Amphetamine-Related Disorders in 2 studies

Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.

Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.

Research Excerpts

ExcerptRelevanceReference
"Buspirone is a dopamine autoreceptor and D3 receptor antagonist and partial agonist at serotonin 1A receptors, making it a logical candidate medication for methamphetamine-use disorder."2.84Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine. ( Lile, JA; Reynolds, AR; Rush, CR; Stoops, WW; Strickland, JC, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reynolds, AR1
Strickland, JC1
Stoops, WW1
Lile, JA1
Rush, CR1
Paterson, NE1
Vocci, F1
Sevak, RJ1
Wagreich, E1
London, ED1

Reviews

1 review available for buspirone and Amphetamine-Related Disorders

ArticleYear
Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.
    The American journal of drug and alcohol abuse, 2014, Volume: 40, Issue:1

    Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Buspirone; Cardiovascular System; Dopam

2014

Trials

1 trial available for buspirone and Amphetamine-Related Disorders

ArticleYear
Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine.
    Drug and alcohol dependence, 2017, 12-01, Volume: 181

    Topics: Administration, Intranasal; Adult; Amphetamine-Related Disorders; Buspirone; Cardiovascular System;

2017